Flt-3 Ligand/FLT3L Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-62304
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to FLT3LG(fms-related tyrosine kinase 3 ligand) The peptide sequence was selected form the N terminal of FLT3LG. Peptide sequence TVLAPAWSPTTYLLLLLLLSSGLSGTQDCSFQHSPISSDFAVKIRELSDY. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for Flt-3 Ligand/FLT3L Antibody
Western Blot: Flt-3 Ligand/FLT3L Antibody [NBP1-62304]
Western Blot: Flt3 ligand Antibody [NBP1-62304] - Human Muscle lysate, concentration 0.2-1 ug/ml.Applications for Flt-3 Ligand/FLT3L Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Flt-3 Ligand/FLT3L
Long Name
fms-like Tyrosine Kinase 3 Ligand
Alternate Names
FLG3L, Flt3L, FLT3LG
Gene Symbol
FLT3LG
OMIM
NP_001450 (Human)
UniProt
Additional Flt-3 Ligand/FLT3L Products
Product Documents for Flt-3 Ligand/FLT3L Antibody
Product Specific Notices for Flt-3 Ligand/FLT3L Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...